Cue Biopharma Inc
CUE0.268USD
-0.074-21.58%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
20.86MMarket Cap
LossP/E TTM
Cue Biopharma Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
9.29M
69.16%
EPS(YoY)
-0.72
34.88%
Analyst Rating
STRONG BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Cue Biopharma Inc?
According to Cue Biopharma Inc's FY2024 earnings report, its total revenue reached 9.29M, with a year-on-year change of 69.16%.
What is the Earnings Per Share (EPS) of Cue Biopharma Inc?
According to Cue Biopharma Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -0.722, with a year-on-year change of 34.88%.
What is the net income of Cue Biopharma Inc?
According to Cue Biopharma Inc's FY2024 earnings report, its net income was -40.67M, with a year-on-year change of 19.83%.
What is the net margin of Cue Biopharma Inc?
According to Cue Biopharma Inc's FY2024 earnings report, its net profit margin was -437.97%, with a year-on-year change of 52.61%.
What is the gross margin of Cue Biopharma Inc?
According to Cue Biopharma Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Cue Biopharma Inc?
According to Cue Biopharma Inc's FY2024 earnings report, its debt-to-asset ratio was 13.46%, with a year-on-year change of 1.43%.
What is the Return on Equity (ROE) of Cue Biopharma Inc?
According to Cue Biopharma Inc's FY2024 earnings report, its Return on Equity (ROE) was -149.03%, with a year-on-year change of -50.94%.
What is the Return on Assets (ROA) of Cue Biopharma Inc?
According to Cue Biopharma Inc's FY2024 earnings report, its Return on Assets (ROA) was -86.80%, with a year-on-year change of -30.72%.
What is the operating profit of Cue Biopharma Inc?
According to Cue Biopharma Inc's FY2024 earnings report, its operating profit was -41.59M, with a year-on-year change of 20.00%.
What are the current assets of Cue Biopharma Inc?
According to Cue Biopharma Inc's FY2024 earnings report, its current assets were 25.14M, with a year-on-year change of -51.14%.
What are the total assets of Cue Biopharma Inc?
According to Cue Biopharma Inc's FY2024 earnings report, its total assets of Cue Biopharma Inc were 32.19M, with a year-on-year change of -47.68%.
What are the total liabilities of Cue Biopharma Inc?
According to Cue Biopharma Inc's FY2024 earnings report, its total liabilities of Cue Biopharma Inc were 14.69M, with a year-on-year change of -39.90%.
What is the total equity of Cue Biopharma Inc?
According to Cue Biopharma Inc's FY2024 earnings report, its total equity of Cue Biopharma Inc was 17.50M, with a year-on-year change of -52.81%.
What is the net operating income of Cue Biopharma Inc?
According to Cue Biopharma Inc's FY2024 earnings report, its net operating income of Cue Biopharma Inc was -40.67M, with a year-on-year change of 19.83%.
What is the net investment of Cue Biopharma Inc?
According to Cue Biopharma Inc's FY2024 earnings report, its net investment of Cue Biopharma Inc was 32.00K, with a year-on-year change of -99.87%.
What is the net financing of Cue Biopharma Inc?
According to Cue Biopharma Inc's FY2024 earnings report, its net financing of Cue Biopharma Inc was 10.24M, with a year-on-year change of -13.63%.
